LBL Biotechnology Inc.
Records under this name other than the patents LBL Biotechnology Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Showing 1 to 4 of 4 · Back to LBL Biotechnology Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,377,441 | Treating Breast Cancer with Anti-IL-19 Antibody Lapsed on the fee record Ended Feb 19, 2025 · High confidence | Lapsed on the fee record | Ended Feb 19, 2025 | High confidence |
| US 8,206,712 | Use of ANTI-IL-20 Antibody for Treating Rheumatoid Arthritis Lapsed on the fee record Ended Jun 26, 2024 · High confidence | Lapsed on the fee record | Ended Jun 26, 2024 | High confidence |
| US 7,435,800 | Antibodies to INTERLEUKIN-20 and Method for Inhibiting INTERLEUKIN-20 Induced Cell Proliferation Term ended Term ended Feb 29, 2024 · Medium confidence | Term ended | Term ended Feb 29, 2024 | Medium confidence |
| US 7,786,274 | ANTI-IL-20 Antibody and Its Use in Treating IL-20 Associated Inflammatory Diseases Lapsed on the fee record Ended Aug 31, 2022 · Medium confidence | Lapsed on the fee record | Ended Aug 31, 2022 | Medium confidence |